Summary: The use of balloon angioplasty with or without coronary artery stenting is limited by the phenomenon of in-stent restenosis (ISR). Until very recently, most efforts to overcome ISR had ...

Braun) DEB (based on PACCOCATH® technology [Bayer//Medrad]) compared with the TAXUS Liberté DES for treatment of ISR in native coronary arteries (n = 131 patients, reference diameter 2.5 mm ...

UPMC Heart and Vascular Institute in central Pennsylvania has treated its first patient with a new therapy.

UPMC Offers New Heart Treatment for Stent Patients UPMC Heart and Vascular Institute in Central Pa. has treated its first patient with a new therapy for in-stent restenosis (ISR), a condition in which ...

Concept Medical has announced the enrollment of the first patient in its MAGICAL-ISR clinical study in the US, evaluating the effectiveness of its MagicTouch Sirolimus drug-coated balloon (DCB).

Concept Medical Receives US FDA IDE Approval For MagicTouch AVF To Improve Haemodialysis Treatment MagicTouch represents a revolutionary advancement in coronary intervention, offering a controlled ...

to commence a pivotal clinical trial for its Prevail coronary paclitaxel drug-coated balloon (DCB). This trial is aimed at treating in-stent restenosis (ISR) and de novo small vessel disease.